SCHEMBL16720241

SCHEMBL16720241

CC(C)(O)n1ccc2c[c]ccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16720047 0.85 — —
SCHEMBL16719574 0.85 — —
SCHEMBL16720401 0.84 — —
SCHEMBL16719593 0.81 — —
SCHEMBL6230903 0.73 NOTUM (0.38) —
SCHEMBL443607 0.72 PRKCI (0.44) —
SCHEMBL6229331 0.71 GRM2 (0.34) —
SCHEMBL18422387 0.70 — —
SCHEMBL1206513 0.69 BUB1 (0.39) —
SCHEMBL1401087 0.69 SLC6A2 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3068758-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE The Wistar Institute Of Anatomy And Biology (US) 2016-09-21 — — EP disclosed
WO-2015073864-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE THE WISAR INSTITUTE OF ANATOMY AND BIOLOGY (US) 2015-05-21 — — WO disclosed
Send feedback